和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688238 和元生物

已收盘 05-12 15:00:00

{"stockData":{"symbol":"688238","market":"SH","secType":"STK","nameCN":"和元生物","latestPrice":5.7,"timestamp":1747033200000,"preClose":5.58,"halted":0,"volume":8083125,"delay":0,"changeRate":0.0215,"floatShares":641000000,"shares":649000000,"eps":-0.5225,"marketStatus":"已收盘","change":0.12,"latestTime":"05-12 15:00:00","open":5.63,"high":5.7,"low":5.54,"amount":45312100,"amplitude":0.0287,"askPrice":5.71,"askSize":573,"bidPrice":5.7,"bidSize":180,"shortable":0,"etf":0,"ttmEps":-0.5225,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747099800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.58,"symbolType":"stock_kcb","openAndCloseTimeList":[[1747013400000,1747020600000],[1747026000000,1747033200000]],"highLimit":6.14,"lowLimit":5.02,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":649036700,"isCdr":false,"pbRate":2.28,"roa":"--","roe":"--","epsLYR":-0.497,"committee":-0.179303,"marketValue":3700000000,"turnoverRate":0.0126,"status":0,"afterMarket":{"amount":0,"volume":0,"close":5.7,"buyVolume":0,"sellVolume":0,"time":1747035238029,"indexStatus":"已收盘 05-12 15:30:00","preClose":5.58},"floatMarketCap":3655000000},"requestUrl":"/m/hq/s/688238","defaultTab":"news","newsList":[{"id":"2534722083","title":"和元生物：变更保荐代表人为王莉","url":"https://stock-news.laohu8.com/highlight/detail?id=2534722083","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534722083?lang=zh_cn&edition=full","pubTime":"2025-05-12 19:30","pubTimestamp":1747049452,"startTime":"0","endTime":"0","summary":"和元生物公告，因原保荐代表人张子慧工作变动， 国泰海通 证券委派王莉接替其持续督导工作。本次变更后，首发项目的保荐代表人为陈恒瑞和王莉，持续督导期至2025年12月31日。公司对张子慧的贡献表示感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512203652a47b65ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512203652a47b65ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2534049117","title":"和元生物股东浙江华睿及一致行动人拟合计减持不超649万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2534049117","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534049117?lang=zh_cn&edition=full","pubTime":"2025-05-09 11:05","pubTimestamp":1746759912,"startTime":"0","endTime":"0","summary":"5月8日，和元生物（688238）发布公告，股东浙江华睿盛银创业投资有限公司及其一致行动人均因资金需求，计划在2025年5月30日至2025年8月29日期间，合计减持不超过649万股，占公司总股本的1%。2025年一季度，和元生物实现收入5285万元，归母净利润-5948万元。文章来源：财中社原标题：和元生物股东浙江华睿及一致行动人拟合计减持不超649万股","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509111919a6d881fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509111919a6d881fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2534142301","title":"因资金需求 和元生物股东华睿盛银及其一致行动人发布减持计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2534142301","media":"银柿财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534142301?lang=zh_cn&edition=full","pubTime":"2025-05-09 11:00","pubTimestamp":1746759648,"startTime":"0","endTime":"0","summary":"近日，和元生物技术（上海）股份有限公司发布股东减持股份计划公告，披露公司股东浙江华睿盛银创业投资有限公司及其一致行动人诸暨富华产业转型升级基金合伙企业、浙江华睿胡庆余堂健康产业投资基金合伙企业、浙江华睿火炬创业投资合伙企业、杭州华睿嘉银股权投资合伙企业、诸暨华睿新锐投资合伙企业拟实施减持计划。上述一致行动人合计持有公司股份37,965,217股，占公司总股本比例5.8495%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509134108a477b04b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509134108a477b04b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2534693113","title":"和元生物：股东华睿盛银拟减持不超过649.04万股，占总股本1.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534693113","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534693113?lang=zh_cn&edition=full","pubTime":"2025-05-09 08:29","pubTimestamp":1746750562,"startTime":"0","endTime":"0","summary":"南财智讯5月9日电，和元生物公告，股东华睿盛银及其一致行动人拟减持不超过649.04万股，占总股本1.00%，减持原因为股东资金需求。减持期间为2025年5月30日至2025年8月29日，减持方式为集中竞价和大宗交易。文章来源：南方财经网原标题：和元生物：股东华睿盛银拟减持不超过649.04万股，占总股本1.00%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509092913a4777072&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509092913a4777072&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2534999441","title":"和元生物(688238.SH)股东华睿盛银及其一致行动人拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2534999441","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534999441?lang=zh_cn&edition=full","pubTime":"2025-05-09 07:28","pubTimestamp":1746746904,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和元生物(688238.SH)公告，公司股东华睿盛银及其一致行动人拟通过集中竞价、大宗交易的方式减持所持公司股份，减持股份数量合计不超过649.04万股，占公司总股本比例不超过1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2533130464","title":"和元生物股东拟减持不超1%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533130464","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533130464?lang=zh_cn&edition=full","pubTime":"2025-05-08 23:10","pubTimestamp":1746717002,"startTime":"0","endTime":"0","summary":"5月8日晚间，和元生物公告，股东华睿盛银及其一致行动人计划通过集中竞价、大宗交易方式减持股份，合计不超过649.04万股，占总股本比例不超1%。此举旨在优化投资结构，减持时间将视市场情况而定。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050823143894f0a54d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050823143894f0a54d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2533137919","title":"和元生物最新公告：股东华睿盛银及其一致行动人拟减持不超过1%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533137919","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533137919?lang=zh_cn&edition=full","pubTime":"2025-05-08 22:59","pubTimestamp":1746716385,"startTime":"0","endTime":"0","summary":"和元生物(688238.SH)公告称，公司股东华睿盛银及其一致行动人拟通过集中竞价、大宗交易的方式减持所持公司股份，减持股份数量合计不超过6,490,367股，占公司总股本比例不超过1%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050800034529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2530402915","title":"和元生物04月28日遭主力抛售339.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530402915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530402915?lang=zh_cn&edition=full","pubTime":"2025-04-28 19:27","pubTimestamp":1745839644,"startTime":"0","endTime":"0","summary":"04月28日, 和元生物股价跌1.09%，报收5.42元，成交金额5585.3万元，换手率1.60%，振幅3.83%，量比0.86。和元生物今日主力资金净流出339.0万元，连续3日净流出，上一交易日主力净流出1887.0万元。该股近5个交易日下跌7.51%，主力资金累计净流出1927.0万元；近20日主力资金累计净流出1.0亿元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428202350a6cba8ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428202350a6cba8ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2529679763","title":"和元生物(688238)3月31日股东户数1.18万户，较上期减少4.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529679763","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529679763?lang=zh_cn&edition=full","pubTime":"2025-04-24 17:11","pubTimestamp":1745485915,"startTime":"0","endTime":"0","summary":"证券之星消息，近日和元生物披露，截至2025年3月31日公司股东户数为1.18万户，较12月31日减少504.0户，减幅为4.1%。户均持股数量由上期的5.28万股增加至5.5万股，户均持股市值为30.25万元。在医疗服务行业个股中，和元生物股东户数低于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.41万户。从股价来看，2024年12月31日至2025年3月31日，和元生物区间涨幅为11.34%，在此期间股东户数减少504.0户，减幅为4.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400028938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2529038946","title":"和元生物04月24日主力净流出242万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2529038946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529038946?lang=zh_cn&edition=full","pubTime":"2025-04-24 15:21","pubTimestamp":1745479313,"startTime":"0","endTime":"0","summary":"04月24日, 和元生物股价跌0.69%，报收5.79元，成交金额7096万元，换手率1.91%，振幅4.29%，量比1.02。和元生物今日主力资金净流出242万元，上一交易日主力净流入229万元。该股近5个交易日上涨3.58%，主力资金累计净流入860万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出181万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424162931a6c649fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424162931a6c649fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2529719945","title":"和元生物一季度亏损同比扩大至5948万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529719945","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529719945?lang=zh_cn&edition=full","pubTime":"2025-04-23 17:44","pubTimestamp":1745401465,"startTime":"0","endTime":"0","summary":"报告期内，CRO业务实现收入1986万元，同比增长10.59%，保持稳定增长；而CDMO业务收入2761万元，同比下降27.74%，主要受订单类型及项目推进情况的影响。公司持续致力于技术创新和专利申请，报告期内新增国内注册商标3项、著作权1项，并申请了2项发明专利和6项实用新型专利。截至报告期末，公司累计拥有发明专利27项，实用新型专利16项，以及65项国内注册商标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042317450994df6241&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042317450994df6241&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2529573160","title":"和元生物(688238.SH)发布一季度业绩，归母净亏损5947.73万元，亏损扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=2529573160","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529573160?lang=zh_cn&edition=full","pubTime":"2025-04-23 17:38","pubTimestamp":1745401111,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和元生物(688238.SH)发布2025年第一季度报告，公司2025年第一季度营业收入5284.77万元，同比下降11.29%;归属于上市公司股东的净亏损5947.73万元，亏损扩大;归属于上市公司股东的扣除非经常性损益的净亏损5959.27万元，亏损扩大;基本每股亏损0.092元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2528016049","title":"每周股票复盘：和元生物（688238）股东户数减少，业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2528016049","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528016049?lang=zh_cn&edition=full","pubTime":"2025-04-19 04:04","pubTimestamp":1745006652,"startTime":"0","endTime":"0","summary":"截至2025年4月18日收盘，和元生物报收于5.68元，较上周的5.43元上涨4.6%。本周，和元生物4月14日盘中最高价报6.14元。4月16日盘中最低价报5.39元。和元生物当前最新总市值36.87亿元，在医疗服务板块市值排名31/50，在两市A股市值排名3454/5146。户均持股数量由上期的5.28万股增加至5.33万股，户均持股市值为29.31万元。业绩披露要点和元生物2024年年报显示，公司主营收入2.48亿元，同比上升21.16%；归母净利润-3.22亿元，同比下降151.54%；扣非净利润-3.36亿元，同比下降151.53%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041900006541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2528107272","title":"和元生物：收入保持增长 期待再生医学突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2528107272","media":"中金公司","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528107272?lang=zh_cn&edition=full","pubTime":"2025-04-19 00:00","pubTimestamp":1744992000,"startTime":"0","endTime":"0","summary":"业绩基本符合市场预期，盈利能力承压主要因下游客户融资仍不及预期需求偏弱，同时公司临港基地投入运营费用增加。发展趋势CDMO：保持国内领先地位，临港基地产能释放。2024 年公司支持客户取得10 个IND 临床默示许可批件，2 个美国FDA 批件，截至2024 年底累计取得44个IND。布局再生医学领域。2024 年4 月公司投资设立全资子公司和元和美，2024年9 月成立和元和美“再生医学中心”，布局再生医学及抗衰应用领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250419185109a45ee04b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250419185109a45ee04b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2528032148","title":"和元生物截止03月31日股东人数1.22万户，人均持股5.26万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2528032148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528032148?lang=zh_cn&edition=full","pubTime":"2025-04-18 15:20","pubTimestamp":1744960805,"startTime":"0","endTime":"0","summary":"和元生物披露公司股东人数最新情况，截止2025年03月31日，公司股东人数为1.22万户，较上期减少319户，环比减少0.99%。在医疗服务行业个股中，和元生物股东户数少于行业平均水平，截至2025年03月31日，医疗服务行业平均股东户数为4.53万户，户均持股市值方面，医疗服务行业A股上市公司户均持股市值为32.57万元，和元生物少于行业平均水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418160238a6bf0841&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418160238a6bf0841&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2528761798","title":"和元生物04月17日主力净流入440万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2528761798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528761798?lang=zh_cn&edition=full","pubTime":"2025-04-17 15:21","pubTimestamp":1744874495,"startTime":"0","endTime":"0","summary":"04月17日, 和元生物股价涨1.82%，报收5.59元，成交金额5599万元，换手率1.56%，振幅4.19%，量比0.54。和元生物今日主力资金净流入440万元，上一交易日主力净流出544万元。该股近5个交易日上涨5.08%，主力资金累计净流出160万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出3948万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417162328a45c34cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417162328a45c34cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2517433243","title":"AI赋能医疗服务企业提质增效，多场景应用覆盖患者全生命诊疗周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2517433243","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517433243?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:32","pubTimestamp":1741332736,"startTime":"0","endTime":"0","summary":"根据国泰君安研报，DeepSeek的突破性技术显著加速AI在医疗行业的应用进程，多场景应用覆盖患者全生命诊疗周期，赋能医疗服务企业提升服务效率和质量，实现降本增效。AI医生能够加速青年医生培养，提升优质医疗资源供给。此外，AI智能助手助力医生在预问诊、电子病历生成和质量控制等方面提升效率。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307153301989f8907&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307153301989f8907&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603259","688073","BK0188","603127","BK0239","BK0284","688710","688238","688222","BK0132","600568","BK0060","600763","603456","BK0077","688202","688621","688131","BK0139","688046","688265","600721","688315","603882"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1747080282332,"stockEarnings":[{"period":"1week","weight":0.0053},{"period":"1month","weight":0.0497},{"period":"3month","weight":0.0899},{"period":"6month","weight":-0.1009},{"period":"1year","weight":-0.0806},{"period":"ytd","weight":0.1538}],"compareEarnings":[{"period":"1week","weight":0.0275},{"period":"1month","weight":0.0405},{"period":"3month","weight":0.0154},{"period":"6month","weight":-0.0204},{"period":"1year","weight":0.0681},{"period":"ytd","weight":0.0052}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"和元生物技术(上海)股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"11799人(较上一季度减少4.10%)","perCapita":"54338股","listingDate":"2022-03-22","address":"上海市浦东新区国际医学园区紫萍路908弄19号楼","registeredCapital":"64903万元","survey":"　　和元生物技术(上海)股份有限公司是一家聚焦基因治疗领域的生物科技公司，专注于为基因治疗的基础研究提供基因治疗载体研制、基因功能研究等CRO服务，以及为基因药物的研发提供IND-CMC药学研究、临床样品GMP生产等CDMO服务。主要产品有基因治疗CRO、基因治疗CDMO、生物制剂、试剂。","listedPrice":13.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和元生物,688238,和元生物股票,和元生物股票老虎,和元生物股票老虎国际,和元生物行情,和元生物股票行情,和元生物股价,和元生物股市,和元生物股票价格,和元生物股票交易,和元生物股票购买,和元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}